Contact Us

Service Line:+1-315-239-3085

Address:FL-4, Building A5, International Enterprise Community, Tianjin, China

Email:info@kmdbioscience.com

Online Inquery

  •   
  •   
  •   
  • Refresh

Anti-Human TNFA Recombinant Antibody(Infliximab)

Product Information
Catalog Number YR1094
Product Name Anti-Human TNFA Recombinant Antibody(Infliximab)
Molecular Name Infliximab
Alias Anti-TNFA Recombinant Antibody, Research Grade Infliximab
CAS Number 170277-31-3
Molecular Weight 149 kDa
Target TNFA[Homo sapiens]
Isotype IgG1 Kappa
Clonity Monoclonal
Host Mouse
Source CHO Cells
Size 1mg, 5mg
Concentration 1mg/ml
Purity >95% as determined by SDS-PAGE
Applications IF, IP, Neut, FuncS, ELISA, FCM, WB
Buffer PBS, pH7.5
Background Infliximab, a chimeric monoclonal antibody, sold under the brand name Remicade among others, is a medication used to treat a number of autoimmune diseases. This includes Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, and Behçet's disease.
Storage It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note This product is for research use only.